Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
1.
Integr Zool ; 16(6): 886-892, 2021 Nov.
Article in English | MEDLINE | ID: mdl-33733592

ABSTRACT

The epidemiology of Yersinia pestis, the causative agent of plague, involves vectors and reservoirs in its transmission cycle. The passive plague surveillance in Madagascar targets mainly rodent and fleas. However, carnivores are routinely surveyed as sentinels of local plague activity in some countries. The aim of this study is to assess the use of domestic dog (Canis familiaris) as sentinel animal for field surveillance of plague in a highly endemic area in Madagascar. Cross-sectional surveys of plague antibody prevalence in C. familiaris were conducted in endemic areas with contrasting histories of plague cases in humans, as well as a plague free area. Rodent capture was done in parallel to evaluate evidence for Y. pestis circulation in the primary reservoirs. In 2 sites, dogs were later re-sampled to examine evidence of seroconversion and antibody persistence. Biological samplings were performed between March 2008 and February 2009. Plague antibody detection was assessed using anti-F1 ELISA. Our study showed a significant difference in dog prevalence rates between plague-endemic and plague-free areas, with no seropositive dogs detected in the plague free area. No correlation was found between rodents and dog prevalence rates, with an absence of seropositive rodents in some area where plague circulation was indicated by seropositive dogs. This is consistent with high mortality rates in rodents following infection. Re-sampling dogs identified individuals seropositive on both occasions, indicating high rates of re-exposure and/or persistence of plague antibodies for at least 9 months. Seroconversion or seropositive juvenile dogs indicated recent local plague circulation. In Madagascar, dog surveillance for plague antibody could be useful to identify plague circulation in new areas or quiescent areas within endemic zones. Within active endemic areas, monitoring of dog populations for seroconversion (negative to positive) or seropositive juvenile dogs could be useful for identifying areas at greatest risk of human outbreaks.


Subject(s)
Dog Diseases/epidemiology , Endemic Diseases , Plague/veterinary , Sentinel Species , Sentinel Surveillance , Animals , Antibodies, Bacterial/blood , Bacterial Zoonoses/prevention & control , Disease Outbreaks/prevention & control , Dog Diseases/blood , Dogs , Humans , Madagascar/epidemiology , Plague/epidemiology , Plague/microbiology , Prevalence
2.
Emerg Infect Dis ; 25(2): 220-228, 2019 02.
Article in English | MEDLINE | ID: mdl-30666930

ABSTRACT

Madagascar is more seriously affected by plague, a zoonosis caused by Yersinia pestis, than any other country. The Plague National Control Program was established in 1993 and includes human surveillance. During 1998-2016, a total of 13,234 suspected cases were recorded, mainly from the central highlands; 27% were confirmed cases, and 17% were presumptive cases. Patients with bubonic plague (median age 13 years) represented 93% of confirmed and presumptive cases, and patients with pneumonic plague (median age 29 years) represented 7%. Deaths were associated with delay of consultation, pneumonic form, contact with other cases, occurrence after 2009, and not reporting dead rats. A seasonal pattern was observed with recrudescence during September-March. Annual cases peaked in 2004 and decreased to the lowest incidence in 2016. This overall reduction occurred primarily for suspected cases and might be caused by improved adherence to case criteria during widespread implementation of the F1 rapid diagnostic test in 2002.


Subject(s)
Plague/epidemiology , Yersinia pestis , Antigens, Bacterial/immunology , Case-Control Studies , Data Analysis , Disease Outbreaks , History, 20th Century , History, 21st Century , Humans , Immunoassay , Madagascar/epidemiology , Plague/diagnosis , Plague/history , Plague/microbiology , Population Surveillance , Risk Factors , Seroepidemiologic Studies , Yersinia pestis/immunology
3.
Virol J ; 11: 61, 2014 Mar 31.
Article in English | MEDLINE | ID: mdl-24684835

ABSTRACT

BACKGROUND: The epidemiology of dengue in the South Pacific has been characterized by transmission of a single dominant serotype for 3-5 years, with subsequent replacement by another serotype. From 2001 to 2008 only DENV-1 was reported in the Pacific. In 2008, DENV-4 emerged and quickly displaced DENV-1 in the Pacific, except in New Caledonia (NC) where DENV-1 and DENV-4 co-circulated in 2008-2009. During 2012-2013, another DENV-1 outbreak occurred in NC, the third DENV-1 outbreak in a decade. Given that dengue is a serotype-specific immunizing infection, the recurrent outbreaks of a single serotype within a 10-year period was unexpected. FINDINGS: This study aimed to inform this phenomenon by examining the phylogenetic characteristics of the DENV-1 viruses in NC and other Pacific islands between 2001 and 2013. As a result, we have demonstrated that NC experienced introductions of viruses from both the Pacific (genotype IV) and South-east Asia (genotype I). Moreover, whereas genotype IV and I were co-circulating at the beginning of 2012, we observed that from the second half of 2012, i.e. during the major DENV-1 outbreak, all analyzed viruses were genotype I suggesting that a genotype switch occurred. CONCLUSIONS: Repeated outbreaks of the same dengue serotype, as observed in NC, is uncommon in the Pacific islands. Why the earlier DENV-1 outbreaks did not induce sufficient herd immunity is unclear, and likely multifactorial, but the robust vector control program may have played a role by limiting transmission and thus maintaining a large susceptible pool in the population.


Subject(s)
Dengue Virus/classification , Dengue Virus/genetics , Dengue/epidemiology , Dengue/virology , Cluster Analysis , Dengue Virus/isolation & purification , Humans , Molecular Epidemiology , Molecular Sequence Data , New Caledonia/epidemiology , Phylogeny , RNA, Viral/genetics , Sequence Analysis, DNA
4.
Trans R Soc Trop Med Hyg ; 108(4): 183-4, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24627423

ABSTRACT

We comment on a unique country-wide scale field evaluation of rapid diagnostic test (RDT) for meningococcal meningitis in Niger. The authors reported the good sensitivity and specificity of the test, and the reliability of results obtained in the field by non-specialized health staff. This finding allows us to consider RDT as a good candidate laboratory tool to be used for the case-based surveillance system, post introduction of the new conjugate A vaccine (MenAfriVac) in the African meningitis belt countries. In addition, RDT is also a potential point of care test to improve the management of meningitis patients.


Subject(s)
Diagnostic Tests, Routine/standards , Meningitis, Meningococcal/diagnosis , Humans , Meningitis, Meningococcal/prevention & control , Meningococcal Vaccines , Niger , Reagent Kits, Diagnostic , Reproducibility of Results , Sensitivity and Specificity
5.
PLoS Negl Trop Dis ; 7(6): e2289, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23826401

ABSTRACT

Background : Leptospirosis is a growing public health concern in many tropical and subtropical countries. However, its diagnosis is difficult because of non-specific symptoms and concurrent other endemic febrile diseases. In many regions, the laboratory diagnosis is not available due to a lack of preparedness and simple diagnostic assay or difficult access to reference laboratories. Yet, an early antibiotic treatment is decisive to the outcome. The need for Rapid Diagnostic Tests (RDTs) for bedside diagnosis of leptospirosis has been recognized. We developed a vertical flow immunochromatography strip RDT detecting anti-Leptospira human IgM and evaluated it in patients from New Caledonia, France, and French West Indies. Methodology/Principal Findings : Whole killed Leptospira fainei cells were used as antigen for the test line and purified human IgM as the control line. The mobile phase was made of gold particles conjugated with goat anti-human IgM. Standards for Reporting of Diagnostic Accuracy criteria were used to assess the performance of this RDT. The Microscopic Agglutination Test (MAT) was used as the gold standard with a cut-off titer of ≥400. The sensitivity was 89.8% and the specificity 93.7%. Positive and negative Likelihood Ratios of 14.18 and 0.108 respectively, and a Diagnostic Odds Ratio of 130.737 confirmed its usefulness. This RDT had satisfactory reproducibility, repeatability, thermal tolerance and shelf-life. The comparison with MAT evidenced the earliness of the RDT to detect seroconversion. When compared with other RDT, the Vertical Flow RDT developed displayed good diagnostic performances. CONCLUSIONS/SIGNIFICANCE: This RDT might be used as a point of care diagnostic tool in limited resources countries. An evaluation in field conditions and in other epidemiological contexts should be considered to assess its validity over a wider range of serogroups or when facing different endemic pathogens. It might prove useful in endemic contexts or outbreak situations.

6.
mBio ; 4(1): e00623-12, 2013 Feb 12.
Article in English | MEDLINE | ID: mdl-23404402

ABSTRACT

UNLABELLED: A cluster of human plague cases occurred in the seaport city of Mahajanga, Madagascar, from 1991 to 1999 following 62 years with no evidence of plague, which offered insights into plague pathogen dynamics in an urban environment. We analyzed a set of 44 Mahajanga isolates from this 9-year outbreak, as well as an additional 218 Malagasy isolates from the highland foci. We sequenced the genomes of four Mahajanga strains, performed whole-genome sequence single-nucleotide polymorphism (SNP) discovery on those strains, screened the discovered SNPs, and performed a high-resolution 43-locus multilocus variable-number tandem-repeat analysis of the isolate panel. Twenty-two new SNPs were identified and defined a new phylogenetic lineage among the Malagasy isolates. Phylogeographic analysis suggests that the Mahajanga lineage likely originated in the Ambositra district in the highlands, spread throughout the northern central highlands, and was then introduced into and became transiently established in Mahajanga. Although multiple transfers between the central highlands and Mahajanga occurred, there was a locally differentiating and dominant subpopulation that was primarily responsible for the 1991-to-1999 Mahajanga outbreaks. Phylotemporal analysis of this Mahajanga subpopulation revealed a cycling pattern of diversity generation and loss that occurred during and after each outbreak. This pattern is consistent with severe interseasonal genetic bottlenecks along with large seasonal population expansions. The ultimate extinction of plague pathogens in Mahajanga suggests that, in this environment, the plague pathogen niche is tenuous at best. However, the temporary large pathogen population expansion provides the means for plague pathogens to disperse and become ecologically established in more suitable nonurban environments. IMPORTANCE: Maritime spread of plague led to the global dissemination of this disease and affected the course of human history. Multiple historical plague waves resulted in massive human mortalities in three classical plague pandemics: Justinian (6th and 7th centuries), Middle Ages (14th to 17th centuries), and third (mid-1800s to the present). Key to these events was the pathogen's entry into new lands by "plague ships" via seaport cities. Although initial disease outbreaks in ports were common, they were almost never sustained for long and plague pathogens survived only if they could become established in ecologically suitable habitats. Although plague pathogens' ability to invade port cities has been essential for intercontinental spread, these regions have not proven to be a suitable long-term niche. The disease dynamics in port cities such as Mahajanga are thus critical to plague pathogen amplification and dispersal into new suitable ecological niches for the observed global long-term maintenance of plague pathogens.


Subject(s)
Plague/epidemiology , Plague/transmission , Yersinia pestis/classification , Yersinia pestis/genetics , Animals , Cluster Analysis , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Genome, Bacterial , Genotype , Humans , Madagascar/epidemiology , Minisatellite Repeats , Molecular Epidemiology , Molecular Sequence Data , Molecular Typing , Pandemics , Phylogeny , Polymorphism, Single Nucleotide , Sequence Analysis, DNA , Yersinia pestis/isolation & purification
7.
J Clin Virol ; 55(1): 23-9, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22695001

ABSTRACT

BACKGROUND: In Pacific Island Countries (PICs) the epidemiology of dengue is characterized by long-term transmission of a single dengue virus (DENV) serotype. The emergence of a new serotype in one island country often indicates major outbreaks with this serotype will follow in other PICs. OBJECTIVES: Filter paper (FP) cards on which whole blood or serum from dengue suspected patients had been dried was evaluated as a method for transportation of this material by standard mail delivery throughout the Pacific. STUDY DESIGN: Twenty-two FP-dried whole blood samples collected from patients in New Caledonia and Wallis & Futuna Islands, during DENV-1 and DENV-4 transmission, and 76 FP-dried sera collected from patients in Yap State, Majuro (Republic of Marshall Islands), Tonga and Fiji, before and during outbreaks of DENV-2 in Yap State and DENV-4 in Majuro, were tested for the presence of DENV RNA, by serotype specific RT-PCR, at the Institut Louis Malardé in French Polynesia. RESULTS: The serotype of DENV could be determined, by a variety of RT-PCR procedures, in the FP-dried samples after more than three weeks of transport at ambient temperatures. In most cases, the sequencing of the envelope gene to genotype the viruses also was possible. CONCLUSIONS: The serotype and genotype of DENV can be determined from FP-dried serum or whole blood samples transported over thousands of kilometers at ambient, tropical, temperatures. This simple and low-cost approach to virus identification should be evaluated in isolated and resource poor settings for surveillance for a range of significant viral diseases.


Subject(s)
Dengue Virus/isolation & purification , Dengue/blood , Dried Blood Spot Testing/methods , Public Health Surveillance/methods , Adolescent , Adult , Aged , Child , Child, Preschool , Dengue/diagnosis , Dengue/virology , Dengue Virus/classification , Dengue Virus/genetics , Female , Humans , Infant , Male , Middle Aged , Pacific Islands , Phylogeny , RNA, Viral/blood , Real-Time Polymerase Chain Reaction , Viral Envelope Proteins/genetics
8.
J Clin Virol ; 53(3): 214-8, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22240388

ABSTRACT

BACKGROUND: KSHV/HHV-8 is the etiological agent of Kaposi's sarcoma, primary effusion lymphoma and most multicentric Castleman's disease cases. KSHV exhibits a high genetic variability comprising five genotypes (A-E). Few data are yet available concerning the situation of KSHV, its genetic variability and the associated diseases in Melanesia. OBJECTIVES: We performed a study on 626 natives Melanesians from New Caledonia and Vanikoro Island to evaluate KSHV seroprevalence and characterize molecularly the viral strains. STUDY DESIGN: Plasma from 343 males and 283 females (age range: 15-86 years, mean age: 60) were tested for KSHV latent antibodies by an immunofluorescence assay (IFA) using BC-3 cells. DNAs extracted from peripheral blood buffy-coat of KSHV seropositive individuals were amplified to obtain a 737-bp fragment of the ORF-K1 gene. Phylogenetic analyses were then performed. RESULTS: Among 626 samples, 148 were IFA positive (dilution≥1:80). The overall seroprevalence was 23.6% (25.2% in New Caledonia, 17.5% in Vanikoro). Fifteen (8 men and 7 women, mean age 69 years) out of 148 DNA samples were found PCR positive. All ORF-K1 sequences belonged to KSHV genotype D. A geographic clustering according to the island of origin of KSHV infected persons was clearly observed with sequences from New Caledonia clustering with most Vanuatu strains. CONCLUSIONS: New Caledonia and Vanikoro are endemic for KSHV with a high diversity of genotype D variants. These strains were probably introduced into New Caledonia during multiple waves of migrations of Melanesian and Polynesian individuals that have colonized this archipelago.


Subject(s)
Herpesviridae Infections/virology , Herpesvirus 8, Human/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Antibodies, Viral/blood , Cluster Analysis , DNA, Viral/blood , DNA, Viral/chemistry , Female , Herpesviridae Infections/epidemiology , Herpesvirus 8, Human/classification , Herpesvirus 8, Human/genetics , Herpesvirus 8, Human/immunology , Humans , Male , Melanesia/epidemiology , Middle Aged , Phylogeny
9.
PLoS Negl Trop Dis ; 5(9): e1319, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21931876

ABSTRACT

BACKGROUND: Plague was introduced to Madagascar in 1898 and continues to be a significant human health problem. It exists mainly in the central highlands, but in the 1990s was reintroduced to the port city of Mahajanga, where it caused extensive human outbreaks. Despite its prevalence, the phylogeography and molecular epidemiology of Y. pestis in Madagascar has been difficult to study due to the great genetic similarity among isolates. We examine island-wide geographic-genetic patterns based upon whole-genome discovery of SNPs, SNP genotyping and hypervariable variable-number tandem repeat (VNTR) loci to gain insight into the maintenance and spread of Y. pestis in Madagascar. METHODOLOGY/PRINCIPAL FINDINGS: We analyzed a set of 262 Malagasy isolates using a set of 56 SNPs and a 43-locus multi-locus VNTR analysis (MLVA) system. We then analyzed the geographic distribution of the subclades and identified patterns related to the maintenance and spread of plague in Madagascar. We find relatively high levels of VNTR diversity in addition to several SNP differences. We identify two major groups, Groups I and II, which are subsequently divided into 11 and 4 subclades, respectively. Y. pestis appears to be maintained in several geographically separate subpopulations. There is also evidence for multiple long distance transfers of Y. pestis, likely human mediated. Such transfers have resulted in the reintroduction and establishment of plague in the port city of Mahajanga, where there is evidence for multiple transfers both from and to the central highlands. CONCLUSIONS/SIGNIFICANCE: The maintenance and spread of Y. pestis in Madagascar is a dynamic and highly active process that relies on the natural cycle between the primary host, the black rat, and its flea vectors as well as human activity.


Subject(s)
Plague/epidemiology , Plague/microbiology , Yersinia pestis/genetics , Analysis of Variance , Cluster Analysis , DNA, Bacterial/chemistry , Humans , Madagascar/epidemiology , Minisatellite Repeats/genetics , Molecular Epidemiology/methods , Molecular Typing , Phylogeography , Polymerase Chain Reaction , Polymorphism, Single Nucleotide/genetics
10.
PLoS One ; 4(10): e7326, 2009 Oct 05.
Article in English | MEDLINE | ID: mdl-19802392

ABSTRACT

The Pastorex((R)) (BioRad) rapid agglutination test is one of the main rapid diagnostic tests (RDTs) for meningococcal disease currently in use in the "meningitis belt". Earlier evaluations, performed after heating and centrifugation of cerebrospinal fluid (CSF) samples, under good laboratory conditions, showed high sensitivity and specificity. However, during an epidemic, the test may be used without prior sample preparation. Recently a new, easy-to-use dipstick RDT for meningococcal disease detection on CSF was developed by the Centre de Recherche Médicale et Sanitaire in Niger and the Pasteur Institute in France. We estimate diagnostic accuracy in the field during the 2006 outbreak of Neisseria meningitidis serogroup A in Maradi, Niger, for the dipstick RDT and Pastorex((R)) on unprepared CSF, (a) by comparing each test's sensitivity and specificity with previously reported values; and (b) by comparing results for each test on paired samples, using McNemar's test. We also (c) estimate diagnostic accuracy of the dipstick RDT on diluted whole blood. We tested unprepared CSF and diluted whole blood from 126 patients with suspected meningococcal disease presenting at four health posts. (a) Pastorex((R)) sensitivity (69%; 95%CI 57-79) was significantly lower than found previously for prepared CSF samples [87% (81-91); or 88% (85-91)], as was specificity [81% (95%CI 68-91) vs 93% (90-95); or 93% (87-96)]. Sensitivity of the dipstick RDT [89% (95%CI 80-95)] was similar to previously reported values for ideal laboratory conditions [89% (84-93) and 94% (90-96)]. Specificity, at 62% (95%CI 48-75), was significantly lower than found previously [94% (92-96) and 97% (94-99)]. (b) McNemar's test for the dipstick RDT vs Pastorex((R)) was statistically significant (p<0.001). (c) The dipstick RDT did not perform satisfactorily on diluted whole blood (sensitivity 73%; specificity 57%).Sensitivity and specificity of Pastorex((R)) without prior CSF preparation were poorer than previously reported results from prepared samples; therefore we caution against using this test during an epidemic if sample preparation is not possible. For the dipstick RDT, sensitivity was similar to, while specificity was not as high as previously reported during a more stable context. Further studies are needed to evaluate its field performance, especially for different populations and other serogroups.


Subject(s)
Meningitis, Meningococcal/blood , Meningitis, Meningococcal/cerebrospinal fluid , Meningitis, Meningococcal/diagnosis , Neisseria meningitidis, Serogroup A/immunology , Reagent Kits, Diagnostic , Disease Outbreaks , Humans , Niger , Polymerase Chain Reaction , Reproducibility of Results , Sensitivity and Specificity , Serotyping
11.
Mem Inst Oswaldo Cruz ; 104(3): 441-3, 2009 May.
Article in English | MEDLINE | ID: mdl-19547869

ABSTRACT

This is the first study describing the genetic polymorphism of Mycobacterium tuberculosis strains in the Indian Ocean Region. Using IS6110 RFLP analysis, 475 M. tuberculosis isolates from Madagascar, Comoros, Mauritius, Mozambique and La Reunion were compared. Of the 332 IS6110 profiles found, 43 were shared by clusters containing 2-65 strains. Six clusters were common to at least two countries. Of 52 families of strains with similar IS6110 profiles, 10 were common to at least two countries. Interestingly, another characteristic was the frequency (16.8%) of IS6110 single-copy strains. These strains could be distinguished using the DR marker. This preliminary evaluation suggests genetic similarity between the strains of the Indian Ocean Region. However, additional markers would be useful for epidemiological studies and to assess the ancient transmission of strains between countries of this region.


Subject(s)
Mycobacterium tuberculosis/genetics , Polymorphism, Genetic/genetics , Asia , Cluster Analysis , DNA Fingerprinting , DNA, Bacterial/genetics , Indian Ocean , Polymorphism, Restriction Fragment Length
12.
Mem. Inst. Oswaldo Cruz ; 104(3): 441-443, May 2009. ilus, graf
Article in English | LILACS | ID: lil-517008

ABSTRACT

This is the first study describing the genetic polymorphism of Mycobacterium tuberculosis strains in the Indian Ocean Region. Using IS6110 RFLP analysis, 475 M. tuberculosis isolates from Madagascar, Comoros, Mauritius, Mozambique and La Reunion were compared. Of the 332 IS6110 profiles found, 43 were shared by clusters containing 2-65 strains. Six clusters were common to at least two countries. Of 52 families of strains with similar IS6110 profiles, 10 were common to at least two countries. Interestingly, another characteristic was the frequency (16.8 percent) of IS6110 single-copy strains. These strains could be distinguished using the DR marker. This preliminary evaluation suggests genetic similarity between the strains of the Indian Ocean Region. However, additional markers would be useful for epidemiological studies and to assess the ancient transmission of strains between countries of this region.


Subject(s)
Mycobacterium tuberculosis/genetics , Polymorphism, Genetic/genetics , Asia , Cluster Analysis , DNA Fingerprinting , DNA, Bacterial/genetics , Indian Ocean , Polymorphism, Restriction Fragment Length
13.
PLoS Negl Trop Dis ; 2(5): e241, 2008 May 28.
Article in English | MEDLINE | ID: mdl-18509472

ABSTRACT

BACKGROUND: In the framework of the monitoring and evaluation of the Nigerian schistosomiasis and soil-transmitted helminth control programme, a follow-up of children took place in eight sentinel sites. The objective of the study was to assess the evolution of Schistosoma haematobium infection and anaemia in schoolchildren after a single administration of praziquantel (PZQ) and albendazole. METHODS/PRINCIPAL FINDINGS: Pre-treatment examination and follow-up at one year post-treatment of schoolchildren aged 7, 8, and 11 years, including interview, urine examination, ultrasound examination of the urinary tract, and measurement of haemoglobin. Before treatment, the overall prevalence of S. heamatobium infection was 75.4% of the 1,642 enrolled children, and 21.8% of children excreted more than 50 eggs/10 ml urine. Prevalence increased with age. The overall prevalence of anaemia (haemoglobin <11.5 g/dl) was 61.6%, decreasing significantly with increasing age. The mean haemoglobinemia was 11 g/dl. In bivariate analysis, anaemia was significantly more frequent in children infected with S. haematobium, although it was not correlated to the intensity of infection. Anaemia was also associated with micro-haematuria and to kidney distensions. In a sub-sample of 636 children tested for P. falciparum infection, anaemia was significantly more frequent in malaria-infected children. In multivariate analysis, significant predictors of anaemia were P. falciparum infection, kidney distension, and the village. One year after a single-dose praziquantel treatment (administered using the WHO PZQ dose pole) co-administered with albendazole (400 mg single dose) for de-worming, the prevalence of S. haematobium infection was 38%, while the prevalence of anaemia fell to 50.4%. The mean haemoglobinemia showed a statistically significant increase of 0.39 g/dl to reach 11.4 g/dl. Anaemia was no longer associated with S. haematobium or to P. falciparum infections, or to haematuria or ultrasound abnormalities of the urinary tract. CONCLUSIONS: The high prevalence of anaemia in Nigerian children is clearly a result of many factors and not of schistosomiasis alone. Nevertheless, treatment of schistosomiasis and de-worming were followed by a partial, but significant, reduction of anaemia in schoolchildren, not explainable by any other obvious intervention.


Subject(s)
Anemia/etiology , Anthelmintics/therapeutic use , Praziquantel/therapeutic use , Schistosomiasis/complications , Schistosomiasis/drug therapy , Anemia/epidemiology , Child , Female , Humans , Male , Nigeria , Schistosomiasis/pathology , Treatment Outcome
14.
Trans R Soc Trop Med Hyg ; 102(1): 99-100, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17976669

ABSTRACT

Large-scale Neisseria meningitidis (Nm) carriage studies in Africa are hampered by the lack of easy-to-perform and reliable methods for serogrouping strains that are largely polyagglutinable or autoagglutinable isolates using the conventional agglutination method. We tested the recently developed duplex rapid diagnostic tests (RDT1 Nm A and Y/W135, RDT2 Nm C and Y) for the serogrouping of 55 non-interpretable carriage strains. Thirteen (23.6%) could be serogrouped, of which nine were serogroup W135. Rapid diagnostic tests are a useful and efficient tool for the identification and serogrouping of Nm for carriage studies.


Subject(s)
Meningitis, Meningococcal/microbiology , Neisseria meningitidis/classification , Serotyping/methods , Africa , Agglutination Tests , Carrier State/microbiology , Humans , Meningitis, Meningococcal/immunology , Neisseria meningitidis/immunology , Predictive Value of Tests , Reagent Kits, Diagnostic , Reproducibility of Results
15.
Vaccine ; 25 Suppl 1: A30-6, 2007 Sep 03.
Article in English | MEDLINE | ID: mdl-17517452

ABSTRACT

Laboratory diagnosis is an essential component in surveillance of meningococcal epidemics, as it can inform decision-makers of the Neisseria meningitidis serogroup(s) involved and the most appropriate vaccine to be selected for mass vaccination. However, countries most affected face real limitations in laboratory diagnostics, due to lack of resources. We describe current diagnostic tools and examine their cost-effectiveness for use in an epidemic context. The conclusion is that current WHO recommendations to use only the latex agglutination assay (Pastorex) at epidemic onset is cost-effective, but recently developed rapid diagnostic tests for the major epidemic-causing meningococcal serogroups may prove a breakthrough for the future.


Subject(s)
Meningitis, Meningococcal/diagnosis , Meningitis, Meningococcal/prevention & control , Africa/epidemiology , Humans , Latex Fixation Tests/economics , Latex Fixation Tests/methods , Leukocyte Count/economics , Leukocyte Count/methods , Meningitis, Meningococcal/epidemiology , Polymerase Chain Reaction/economics , Polymerase Chain Reaction/methods , Reproducibility of Results , Sensitivity and Specificity
16.
Vaccine ; 25 Suppl 1: A53-7, 2007 Sep 03.
Article in English | MEDLINE | ID: mdl-17517454

ABSTRACT

This study investigated the carriage of Neisseria meningitidis group W135 (NmW135) belonging to sequence type (ST)-2881, ST-11 and NmA ST-7, as these three lineages have been responsible for sporadic cases in 2003 in Niamey (Niger). ST-7 and ST-11 were also the two genotypes involved in recent outbreaks in the African meningitis belt. Among the 97 Nm isolates obtained from 287 schoolchildren swabbed three times, 1 was identified as NmA, 34 as NmW135, 8 as NmY and 54 were non-groupable (NG). Among the 86 isolates genotyped, 59.3% belonged to ST-192, 24.4% to ST-2881, 5.8% to ST-2880, 4.6% to ST-175, 3.5% to ST-4899, 1.2% to ST-11 and 1.2% to ST-7. Most of the isolates recovered were weakly pathogenic Nm NG ST-192 and NmW135 ST-2881. These results, although preliminary, are important to consider before introduction of a NmA conjugate meningococcal vaccine in Africa.


Subject(s)
Meningitis, Meningococcal/epidemiology , Neisseria meningitidis, Serogroup W-135/isolation & purification , Pharynx/microbiology , DNA, Bacterial/analysis , DNA, Bacterial/genetics , Electrophoresis, Gel, Pulsed-Field , Gene Frequency , Genotype , Humans , Meningitis, Meningococcal/immunology , Neisseria meningitidis, Serogroup W-135/classification , Neisseria meningitidis, Serogroup W-135/genetics , Niger/epidemiology
17.
Vaccine ; 25 Suppl 1: A24-9, 2007 Sep 03.
Article in English | MEDLINE | ID: mdl-17521784

ABSTRACT

In the African meningitis belt, reported case-fatality ratio (CFR) for meningitis are usually calculated on the basis of presumed cases. We reviewed 3509 presumed cases of bacterial meningitis reported in Niger for which a cerebrospinal fluid (CSF) sample had been tested later at the reference laboratory. The main aetiologies were Neisseria meningitidis (1496 cases), Streptococcus pneumoniae (303 cases) and Haemophilus influenzae (105 cases). The CFR of meningococcal meningitis was lower for serogroup A (5.5%) than for serogroups X (12%) and W135 (12.7%). With a CFR of 49.8%, pneumococcal meningitis, albeit representing only 20.7% of confirmed cases, accounted for 50% of the deaths. The disease burden of pneumococcal meningitis must be better taken into consideration in the future. As most treatments are presumptive, there is a urgent need for an easy-to-administer, cheap first-line treatment effective on N. meningitidis as well as on S. pneumoniae and H. influenzae that would replace the single-dose oily chloramphenicol treatment which is the most frequent treatment administered today, independent of microbial aetiology and season. The development of diagnostic tools really suitable for remote health facilities also is an urgent challenge.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Meningitis, Bacterial/drug therapy , Meningitis, Bacterial/mortality , Adolescent , Amoxicillin/therapeutic use , Ampicillin/therapeutic use , Ceftriaxone/therapeutic use , Child , Child, Preschool , Chloramphenicol/therapeutic use , Haemophilus influenzae/isolation & purification , Humans , Infant , Infant, Newborn , Meningitis, Bacterial/cerebrospinal fluid , Meningitis, Haemophilus/cerebrospinal fluid , Meningitis, Haemophilus/drug therapy , Meningitis, Haemophilus/mortality , Meningitis, Meningococcal/cerebrospinal fluid , Meningitis, Meningococcal/drug therapy , Meningitis, Meningococcal/mortality , Meningitis, Pneumococcal/cerebrospinal fluid , Meningitis, Pneumococcal/drug therapy , Meningitis, Pneumococcal/mortality , Neisseria meningitidis/isolation & purification , Niger/epidemiology , Streptococcus pneumoniae/isolation & purification , Survival Rate
18.
Clin Infect Dis ; 44(5): 657-63, 2007 Mar 01.
Article in English | MEDLINE | ID: mdl-17278055

ABSTRACT

BACKGROUND: In Niger, epidemic meningococcal meningitis is primarily caused by Neisseria meningitidis (Nm) serogroup A. However, since 2002, Nm serogroup W135 has been considered to be a major threat that has not yet been realized, and an unprecedented incidence of Nm serogroup X (NmX) meningitis was observed in 2006. METHODS: Meningitis surveillance in Niger is performed on the basis of reporting of clinically suspected cases. Cerebrospinal fluid specimens are sent to the reference laboratory in Niamey, Niger. Culture, latex agglutination, and polymerase chain reaction are used whenever appropriate. Since 2004, after the addition of a polymerase chain reaction-based nonculture assay that was developed to genogroup isolates of NmX, polymerase chain reaction testing allows for the identification of Nm serogroup A, Nm serogroup B, Nm serogroup C, NmX, Nm serogroup Y, and Nm serogroup W135. RESULTS: From January to June 2006, a total of 4185 cases of meningitis were reported, and 2905 cerebrospinal fluid specimens were laboratory tested. NmX meningitis represented 51% of 1139 confirmed cases of meningococcal meningitis, but in southwestern Niger, it represented 90%. In the agglomeration of Niamey, the reported cumulative incidence of meningitis was 73 cases per 100,000 population and the cumulative incidence of confirmed NmX meningitis was 27.5 cases per 100,000 population (74.6 cases per 100,000 population in children aged 5-9 years). NmX isolates had the same phenotype (X : NT : P1.5), and all belonged to the same sequence type (ST-181) as the NmX isolates that were circulating in Niamey in the 1990s. Nm serogroup W135 represented only 2.1% of identified meningococci. CONCLUSIONS: This is, to our knowledge, the first report of such a high incidence of NmX meningitis, although an unusually high incidence of NmX meningitis was also observed in the 1990s in Niamey. The increasing incidence of NmX meningitis is worrisome, because no vaccine has been developed against this serogroup. Countries in the African meningitis belt must prepare to face this potential new challenge.


Subject(s)
Meningitis, Meningococcal/epidemiology , Neisseria meningitidis/classification , Disease Outbreaks , Humans , Incidence , Meningitis, Meningococcal/microbiology , Neisseria meningitidis/genetics , Neisseria meningitidis/isolation & purification , Niger/epidemiology , Serotyping
19.
Emerg Infect Dis ; 12(9): 1421-3, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17073093

ABSTRACT

Serogroup W135 ST-2881 meningococci caused a cluster of meningitis cases in Niger in 2003. Of 80 healthy persons in the patients' villages, 28 (35%) carried meningococci; 20 of 21 W135 carrier strains were ST-2881. Ten months later, 5 former carriers were still carriers of W135 ST-2881 strains. The serum bactericidal antibody activity changed according to carrier status.


Subject(s)
Carrier State/epidemiology , Meningitis, Meningococcal/epidemiology , Neisseria meningitidis, Serogroup W-135/isolation & purification , Adolescent , Adult , Aged , Blood Bactericidal Activity , Carrier State/microbiology , Child , Child, Preschool , Female , Humans , Male , Meningitis, Meningococcal/microbiology , Middle Aged , Niger/epidemiology , Prevalence
20.
PLoS Med ; 3(9): e337, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16953658

ABSTRACT

BACKGROUND: Outbreaks of meningococcal meningitis (meningitis caused by Neisseria meningitidis) are a major public health concern in the African "meningitis belt," which includes 21 countries from Senegal to Ethiopia. Of the several species that can cause meningitis, N. meningitidis is the most important cause of epidemics in this region. In choosing the appropriate vaccine, accurate N. meningitidis serogroup determination is key. To this end, we developed and evaluated two duplex rapid diagnostic tests (RDTs) for detecting N. meningitidis polysaccharide (PS) antigens of several important serogroups. METHODS AND FINDINGS: Mouse monoclonal IgG antibodies against N. meningitidis PS A, W135/Y, Y, and C were used to develop two immunochromatography duplex RDTs, RDT1 (to detect serogroups A and W135/Y) and RDT2 (to detect serogroups C and Y). Standards for Reporting of Diagnostic Accuracy criteria were used to determine diagnostic accuracy of RDTs on reference strains and cerebrospinal fluid (CSF) samples using culture and PCR, respectively, as reference tests. The cutoffs were 10(5) cfu/ml for reference strains and 1 ng/ml for PS. Sensitivities and specificities were 100% for reference strains, and 93.8%-100% for CSF serogroups A, W135, and Y in CSF. For CSF serogroup A, the positive and negative likelihood ratios (+/- 95% confidence intervals [CIs]) were 31.867 (16.1-63.1) and 0.065 (0.04-0.104), respectively, and the diagnostic odds ratio (+/- 95% CI) was 492.9 (207.2-1,172.5). For CSF serogroups W135 and Y, the positive likelihood ratio was 159.6 (51.7-493.3) Both RDTs were equally reliable at 25 degrees C and 45 degrees C. CONCLUSIONS: These RDTs are important new bedside diagnostic tools for surveillance of meningococcus serogroups A and W135, the two serogroups that are responsible for major epidemics in Africa.


Subject(s)
Meningitis, Meningococcal/diagnosis , Neisseria meningitidis, Serogroup A/isolation & purification , Neisseria meningitidis, Serogroup C/isolation & purification , Neisseria meningitidis, Serogroup W-135/isolation & purification , Neisseria meningitidis, Serogroup Y/isolation & purification , Reagent Kits, Diagnostic , Africa/epidemiology , Antibodies, Monoclonal , Chromatography/methods , Evaluation Studies as Topic , Humans , Likelihood Functions , Meningitis, Meningococcal/cerebrospinal fluid , Meningitis, Meningococcal/epidemiology , Meningitis, Meningococcal/immunology , Neisseria meningitidis, Serogroup A/immunology , Neisseria meningitidis, Serogroup C/immunology , Neisseria meningitidis, Serogroup W-135/immunology , Neisseria meningitidis, Serogroup Y/immunology , Polymerase Chain Reaction/methods , Predictive Value of Tests , Prospective Studies , Reproducibility of Results , Sensitivity and Specificity , Serotyping , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...